CZ302157B6 - Potahovaná tableta s cyklofosfamidem, zpusob její výroby a zpusob výroby tabletového jádra - Google Patents

Potahovaná tableta s cyklofosfamidem, zpusob její výroby a zpusob výroby tabletového jádra Download PDF

Info

Publication number
CZ302157B6
CZ302157B6 CZ20004489A CZ20004489A CZ302157B6 CZ 302157 B6 CZ302157 B6 CZ 302157B6 CZ 20004489 A CZ20004489 A CZ 20004489A CZ 20004489 A CZ20004489 A CZ 20004489A CZ 302157 B6 CZ302157 B6 CZ 302157B6
Authority
CZ
Czechia
Prior art keywords
weight
cyclophosphamide
talc
magnesium stearate
parts
Prior art date
Application number
CZ20004489A
Other languages
Czech (cs)
English (en)
Other versions
CZ20004489A3 (cs
Inventor
Engel@Jürgen
Rawert@Jürgen
Sauerbier@Dieter
Wichert@Burkhard
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of CZ20004489A3 publication Critical patent/CZ20004489A3/cs
Publication of CZ302157B6 publication Critical patent/CZ302157B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ20004489A 1998-06-15 1999-06-08 Potahovaná tableta s cyklofosfamidem, zpusob její výroby a zpusob výroby tabletového jádra CZ302157B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19826517A DE19826517B4 (de) 1998-06-15 1998-06-15 Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette

Publications (2)

Publication Number Publication Date
CZ20004489A3 CZ20004489A3 (cs) 2001-08-15
CZ302157B6 true CZ302157B6 (cs) 2010-11-18

Family

ID=7870877

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20004489A CZ302157B6 (cs) 1998-06-15 1999-06-08 Potahovaná tableta s cyklofosfamidem, zpusob její výroby a zpusob výroby tabletového jádra

Country Status (29)

Country Link
US (1) US20010046504A1 (pt)
EP (1) EP1089739B1 (pt)
JP (1) JP4891478B2 (pt)
KR (1) KR100679872B1 (pt)
CN (1) CN1177590C (pt)
AR (1) AR019670A1 (pt)
AT (1) ATE310523T1 (pt)
AU (1) AU771284B2 (pt)
BG (1) BG65253B1 (pt)
BR (1) BR9911276A (pt)
CA (1) CA2333682C (pt)
CO (1) CO5070588A1 (pt)
CZ (1) CZ302157B6 (pt)
DE (3) DE19826517B4 (pt)
DK (1) DK1089739T3 (pt)
ES (1) ES2255276T3 (pt)
HK (1) HK1037959A1 (pt)
HU (1) HU226528B1 (pt)
IL (2) IL139944A0 (pt)
NO (1) NO325154B1 (pt)
NZ (1) NZ508888A (pt)
PL (1) PL193398B1 (pt)
RU (1) RU2236231C2 (pt)
SK (1) SK286185B6 (pt)
TR (1) TR200003702T2 (pt)
TW (1) TWI242450B (pt)
UA (1) UA75566C2 (pt)
WO (1) WO1999065499A1 (pt)
ZA (1) ZA200006998B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500063A1 (de) 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
AU2003211146B2 (en) 2002-02-21 2007-07-19 Valeant International (Barbados) Srl Controlled release dosage forms
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
JO3659B1 (ar) * 2010-06-02 2020-08-27 Astellas Deutschland Gmbh أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية
UA112170C2 (uk) 2010-12-10 2016-08-10 Санофі Протипухлинна комбінація, що містить антитіло, яке специфічно розпізнає cd38, і бортезоміб
EP2745833A1 (en) * 2012-12-21 2014-06-25 Institut Gustave Roussy Soluble, dispersible or orodispersible tablets comprising cyclophosphamide
EP3197438A4 (en) 2014-09-26 2018-06-20 Intas Pharmaceuticals Ltd. Pharmaceutical composition having improved content uniformity
JP6814814B2 (ja) 2016-03-17 2021-01-20 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｔａａｒのアゴニストとしての活性を有する５−エチル−４−メチル−ピラゾール−３−カルボキサミド誘導体

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519099A1 (en) * 1988-09-09 1992-12-23 Bristol-Myers Squibb Company Direct compression cyclophosphamide tablet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis
DE4122167A1 (de) * 1990-07-16 1992-01-23 Asta Pharma Ag Tablette und granulat enthaltend als wirkstoff mesna
UA26305A (uk) * 1990-07-16 1999-08-30 Аста Медіка Аг Таблетка, спосіб її одержаhhя, граhулят та спосіб одержаhhя граhулята
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
JP3049095B2 (ja) * 1996-02-22 2000-06-05 サムジン ファーマシューチカル カンパニー，リミテッド 新規抗ウイルス性置換ピリミジンジオン単素炭素環式ヌクレオシド誘導体及びその製造方法とこれを活性成分として含有する組成物
JPH11322596A (ja) * 1998-05-12 1999-11-24 Shionogi & Co Ltd 白金錯体および環状リン酸エステルアミドを含有する抗癌剤
US20040034099A1 (en) * 2002-06-27 2004-02-19 Ramsey Beverly J. Pharmaceutical composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519099A1 (en) * 1988-09-09 1992-12-23 Bristol-Myers Squibb Company Direct compression cyclophosphamide tablet

Also Published As

Publication number Publication date
NZ508888A (en) 2003-11-28
JP2002518334A (ja) 2002-06-25
TR200003702T2 (tr) 2001-06-21
CA2333682C (en) 2008-01-29
DE29921466U1 (de) 2000-03-09
DE59912829D1 (de) 2005-12-29
CN1177590C (zh) 2004-12-01
HUP0102788A3 (en) 2002-12-28
SK286185B6 (sk) 2008-05-06
DK1089739T3 (da) 2006-04-03
NO20006325D0 (no) 2000-12-12
CN1305381A (zh) 2001-07-25
JP4891478B2 (ja) 2012-03-07
RU2236231C2 (ru) 2004-09-20
CO5070588A1 (es) 2001-08-28
US20010046504A1 (en) 2001-11-29
PL193398B1 (pl) 2007-02-28
DE19826517B4 (de) 2006-03-23
AR019670A1 (es) 2002-03-13
AU4508599A (en) 2000-01-05
CA2333682A1 (en) 1999-12-23
HK1037959A1 (en) 2002-03-01
AU771284B2 (en) 2004-03-18
TWI242450B (en) 2005-11-01
ES2255276T3 (es) 2006-06-16
IL139944A0 (en) 2002-02-10
NO325154B1 (no) 2008-02-11
WO1999065499A1 (de) 1999-12-23
ZA200006998B (en) 2001-11-20
EP1089739B1 (de) 2005-11-23
BG65253B1 (bg) 2007-10-31
SK18582000A3 (sk) 2001-08-06
BR9911276A (pt) 2001-10-23
NO20006325L (no) 2000-12-12
KR100679872B1 (ko) 2007-02-07
ATE310523T1 (de) 2005-12-15
BG105139A (en) 2001-07-31
KR20010052819A (ko) 2001-06-25
HU226528B1 (en) 2009-03-30
DE19826517A1 (de) 2000-03-02
PL344832A1 (en) 2001-11-19
HUP0102788A2 (hu) 2002-03-28
EP1089739A1 (de) 2001-04-11
CZ20004489A3 (cs) 2001-08-15
UA75566C2 (en) 2006-05-15
IL139944A (en) 2006-08-01

Similar Documents

Publication Publication Date Title
EP1310245B1 (en) Clopidogrel bisulfate tablet formulation
KR100348842B1 (ko) 염기성물질로안정화된약제학적조성물
US5419917A (en) Controlled release hydrogel formulation
US5047246A (en) Direct compression cyclophosphamide tablet
CZ292069B6 (cs) Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku
EP1266657A1 (en) Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride
EP0315964A1 (en) A novel pharmaceutical composition comprising exifone and water-soluble polymer
CA1298196C (en) Clodronate-containing medicaments and a process for the preparation thereof
CZ302157B6 (cs) Potahovaná tableta s cyklofosfamidem, zpusob její výroby a zpusob výroby tabletového jádra
CS261791A3 (en) Process for preparing preparations in the form of tablets or coated tablets containing light, heat and moisture sensitive active component having a monoclinic crystal structure
SK281193B6 (sk) Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy
SK283249B6 (sk) Tableta vyrobiteľná priamym tabletovaním, obsahujúca aktívnu látku kyselinu 4-amino-1-hydroxybutylidén-1,1-bisfosfónovú a spôsob jej výroby
CA2355239C (en) Pharmaceutical formulations
SK15542003A3 (sk) Topením granulovaný výrobok, spôsob jeho výroby, zmes s jeho obsahom v tuhej tvarovanej farmaceutickej jednotkovej dávkovej forme
CZ280475B6 (cs) Pevné formy pro orální aplikaci, které jako účinnou látku obsahující ifosfamid
WO2007134845A2 (en) Olanzapine pharmaceutical composition
EP3052086A1 (en) Pharmaceutical composition comprising low dose active pharmaceutical ingredient and preparation thereof
SK285236B6 (sk) Farmaceutická kompozícia obsahujúca ciprofloxacína spôsob jej prípravy
PL196485B1 (pl) Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
US20030229101A1 (en) Tablets comprising ciprofloxacin hydrochloride
JP2024531701A (ja) ベムペド酸医薬組成物
JP2019189554A (ja) 溶出性を改善させた医薬組成物
WO2010099150A1 (en) Pharmaceutical tablet and process
WO1996012476A1 (en) Wet granulation formulation for a piperazinylcamphorsulfonyl oxytocin receptor antagonist
MXPA00012079A (en) Cyclophosphamide coated tablets

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of fee

Effective date: 20140608